UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000049406
Receipt No. R000056151
Scientific Title Effectiveness of awareness-raising activities through care managers regarding hepatitis C screening and treatment among elderly persons requiring support and nursing care and their families.
Date of disclosure of the study information 2022/11/11
Last modified on 2022/11/02 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Effectiveness of awareness-raising activities through care managers regarding hepatitis C screening and treatment among elderly persons requiring support and nursing care and their families.
Acronym Effectiveness of Hepatitis C Screening and Awareness Raising by Care Managers
Scientific Title Effectiveness of awareness-raising activities through care managers regarding hepatitis C screening and treatment among elderly persons requiring support and nursing care and their families.
Scientific Title:Acronym Effectiveness of Hepatitis C Screening and Awareness Raising by Care Managers
Region
Japan

Condition
Condition Hepatitis C
Classification by specialty
Hepato-biliary-pancreatic medicine
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Assuming that educating care managers about hepatitis C and providing them with materials to pass on to caregivers and family members may promote hepatitis C screening and treatment, and in order to verify this assumption, we will conduct an intervention study with the cooperation of care managers working at in-home care support facilities in Saga Prefecture, to see to what extent education about hepatitis C and educational activities by providing materials can promote screening and treatment for caregivers and family members requiring care.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes (1) Number of people who have started treatment for hepatitis C
(2) Number of persons tested for hepatitis C
Key secondary outcomes #Attendance rates for training videos
#Evaluation of flyers by caregivers
#Number of flyers distributed and recipients
#Reaction of flyer recipients
#Change in awareness of care managers as a result of this initiative

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control No treatment
Stratification NO
Dynamic allocation YES
Institution consideration Institution is considered as adjustment factor in dynamic allocation.
Blocking NO
Concealment Central registration

Intervention
No. of arms 2
Purpose of intervention Educational,Counseling,Training
Type of intervention
Other
Interventions/Control_1 Web-based training videos on hepatitis C and a confirmation test prior to intervention
Interventions/Control_2 No training videos or confirmation tests on hepatitis C prior to intervention
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria care managers working at in-home care support facilities in Saga Prefecture
Key exclusion criteria Apparent discrepancies in the data reported by care managers
Target sample size 200

Research contact person
Name of lead principal investigator
1st name Hirokazu
Middle name
Last name Takahashi
Organization Saga University Hospital
Division name Liver Center
Zip code 849-0937
Address 5-1-1 Nabeshima, Saga City, Saga Prefecture
TEL 0952-34-3731
Email takahas2@cc.saga-u.ac.jp

Public contact
Name of contact person
1st name Luna
Middle name
Last name Tanaka
Organization Graduate School of Advanced Health Sciences, Saga University Master's Program
Division name Medical Science
Zip code 849-0937
Address 5-1-1 Nabeshima, Saga City, Saga Prefecture
TEL 0952-34-3731
Homepage URL
Email tanaka@tsutawaru-med.com

Sponsor
Institute Saga University
Institute
Department

Funding Source
Organization Saga University Hospital Liver Center
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Faculty of Medicine, Saga University
Address 5-1-1 Nabeshima, Saga City, Saga Prefecture
Tel 0952-34-3318
Email medsosou@mail.admin.saga-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 11 Month 11 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2022 Year 08 Month 23 Day
Date of IRB
2022 Year 09 Month 28 Day
Anticipated trial start date
2022 Year 12 Month 01 Day
Last follow-up date
2023 Year 07 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2022 Year 11 Month 02 Day
Last modified on
2022 Year 11 Month 02 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056151